Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription

Articles published in
Eur Heart J
    June 2023
  1. VERGALLO R, Patrono C
    Lower income, higher risk: disparities in treatments and outcomes of patients with acute myocardial infarction.
    Eur Heart J. 2023 Jun 2:ehad348. doi: 10.1093.
    >> Share

    May 2023
  2. CREA F
    Ischaemic heart disease: from the celebration of Heberden's description of angina pectoris to novel therapeutic targets for angiogenesis and myocardial fibrosis.
    Eur Heart J. 2023;44:1669-1673.
    >> Share

  3. HEUSCH G, Botker HE, Ferdinandy P, Schulz R, et al
    Primordial non-responsiveness: a neglected obstacle to cardioprotection.
    Eur Heart J. 2023;44:1687-1689.
    >> Share

    To be or not to be admitted to the emergency department for chest pain? A costly dilemma.
    Eur Heart J. 2023;44:1715-1717.
    >> Share

  5. ZHU D, Liu S, Huang K, Li J, et al
    Intrapericardial long non-coding RNA-Tcf21 antisense RNA inducing demethylation administration promotes cardiac repair.
    Eur Heart J. 2023;44:1748-1760.
    >> Share

  6. IDING A, Ten Cate-Hoek A, Ten Cate H
    Determining 'thrombogenicity' in patients with coronary artery disease: what's next?
    Eur Heart J. 2023;44:1729-1731.
    >> Share

  7. NISHI T, Kume T, Uemura S
    Resuscitated sudden cardiac arrest related to intraplaque haemorrhage and coronary artery spasm.
    Eur Heart J. 2023;44:1766.
    >> Share

  8. BAO XL, Dai Y, Lu L, Wang XQ, et al
    Vasostatin-2 associates with coronary collateral vessel formation in diabetic patients and promotes angiogenesis via angiotensin-converting enzyme 2.
    Eur Heart J. 2023;44:1732-1744.
    >> Share

  9. CAMARO C, Aarts GWA, Adang EMM, van Hout R, et al
    Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial.
    Eur Heart J. 2023;44:1705-1714.
    >> Share

  10. BODEN WE, Kaski JC, Berry C
    Reprising Heberden's description of angina pectoris after 250 years.
    Eur Heart J. 2023;44:1684-1686.
    >> Share

  11. EMRICH T, Hell M
    Plaque composition on ultra-high-resolution coronary computed tomography angiography with optical coherence tomography correlation.
    Eur Heart J. 2023;44:1765.
    >> Share

  12. VERGALLO R, Patrono C
    'Atom Heart Mothers': the risk of ischaemic heart disease in women with adverse pregnancy outcomes.
    Eur Heart J. 2023;44:1592-1593.
    >> Share

  13. HAN Y
    Chinese expert consensus on clinical application of percutaneous mechanical circulatory support devices in interventional therapy for patients with complex cardiovascular disease.
    Eur Heart J. 2023;44:1586-1588.
    >> Share

  14. UEMATSU M, Yamada R, Sato A
    Isolated septal myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2023 May 4:ehad252. doi: 10.1093.
    >> Share

    April 2023
  15. GENEST J
    Transient very low LDL-C levels: a legacy effect for cardiovascular prevention?
    Eur Heart J. 2023;44:1418-1420.
    >> Share

  16. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.
    Eur Heart J. 2023;44:1432-1445.
    >> Share

  17. CREA F
    Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding.
    Eur Heart J. 2023;44:1287-1290.
    >> Share

  18. KANG J, Rizas KD, Park KW, Chung J, et al
    Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
    Eur Heart J. 2023;44:1360-1370.
    >> Share

  19. NDREPEPA G, Kastrati A
    P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes.
    Eur Heart J. 2023;44:1371-1373.
    >> Share

  20. GIACOPPO D, Alvarez-Covarrubias HA, Koch T, Cassese S, et al
    Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
    Eur Heart J. 2023;44:1343-1357.
    >> Share

  21. GENTILE D, Iannaccone M, Chieffo A
    Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What's next?
    Eur Heart J. 2023;44:1357-1359.
    >> Share

  22. FEDELE D, Foa A, Pizzi C
    Electrocardiographic tips in a young woman presenting with ST-elevation myocardial infarction.
    Eur Heart J. 2023 Apr 11:ehad178. doi: 10.1093.
    >> Share

  23. PEDICINO D, Volpe M
    Higher hospital readmissions in blacks after acute myocardial infarction: healthcare inequality gaps to fill in secondary prevention.
    Eur Heart J. 2023 Apr 10:ehad179. doi: 10.1093.
    >> Share

  24. HIRANO KI, Higashi M, Nakajima K
    Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy.
    Eur Heart J. 2023;44:1191.
    >> Share

    March 2023
  25. NURMOHAMED NS, Kraaijenhof JM, Mayr M, Nicholls SJ, et al
    Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.
    Eur Heart J. 2023 Mar 29:ehad161. doi: 10.1093.
    >> Share

  26. SAKAI K, Collet C, Matsuo H
    Improvement of angina after treating focal coronary artery disease undetected in resting conditions.
    Eur Heart J. 2023;44:1097.
    >> Share

  27. LIUZZO G, Patrono C
    Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease.
    Eur Heart J. 2023;44:1016-1017.
    >> Share

  28. CIARDETTI N, Nardi G, Di Mario C
    Direct high-frequency intravascular ultrasound visualization of drug delivery after paclitaxel urea eluting balloon angioplasty.
    Eur Heart J. 2023;44:1096.
    >> Share

  29. HONDA Y, Nishihira K, Shibata Y, Asada Y, et al
    Early-phase restenosis following directional coronary atherectomy and paclitaxel-coated balloon angioplasty: a histopathological analysis.
    Eur Heart J. 2023;44:1098.
    >> Share

  30. THIELE H, Desch S, Freund A
    Out-of-hospital cardiac arrest without ST-segment elevation: an alternative focus on priorities?
    Eur Heart J. 2023;44:1055-1057.
    >> Share

  31. JIANG Y, Huang J, Li G, Wang W, et al
    Ozone pollution and hospital admissions for cardiovascular events.
    Eur Heart J. 2023 Mar 10:ehad091. doi: 10.1093.
    >> Share

  32. OZKAN J
    Patient study highlights the need to talk about INOCA.
    Eur Heart J. 2023;44:788-789.
    >> Share

  33. SHEMESH E, Chevli PA, Islam T, German CA, et al
    Circulating ketone bodies and cardiovascular outcomes: the MESA study.
    Eur Heart J. 2023 Mar 6:ehad087. doi: 10.1093.
    >> Share

  34. LEE SH, Kim HK, Ahn JH, Kang MG, et al
    Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction.
    Eur Heart J. 2023 Mar 1:ehad088. doi: 10.1093.
    >> Share

  35. HOJO K, Otsuka K, Kasayuki N
    Plaque rupture after coronary CT angiography.
    Eur Heart J. 2023;44:782.
    >> Share

  36. MAJMUNDAR M, Doshi R, Patel KN, Zala H, et al
    Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010-19.
    Eur Heart J. 2023;44:726-737.
    >> Share

    February 2023

  37. Corrigendum to: Climate and environmental triggers of acute myocardial infarction.
    Eur Heart J. 2023 Feb 25:ehad105. doi: 10.1093.
    >> Share

  38. THOMAS PE, Vedel-Krogh S, Kamstrup PR, Nordestgaard BG, et al
    Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein.
    Eur Heart J. 2023 Feb 21:ehad055. doi: 10.1093.
    >> Share

  39. DIBBEN GO, Faulkner J, Oldridge N, Rees K, et al
    Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis.
    Eur Heart J. 2023;44:452-469.
    >> Share

  40. CREA F
    Optimal management of myocardial infarction: from invasive treatment to secondary prevention and rehabilitation.
    Eur Heart J. 2023;44:431-434.
    >> Share

  41. GRACE SL
    Evidence is indisputable that cardiac rehabilitation provides health benefits and event reduction: time for policy action.
    Eur Heart J. 2023;44:470-472.
    >> Share

  42. MEHTA SR, McGrath BP
    Anatomy vs. physiology: how should we achieve complete revascularization in acute coronary syndromes?
    Eur Heart J. 2023;44:485-487.
    >> Share

  43. PRICE S, Kaski JC, Al-Lamee R, Boden WE, et al
    The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischaemic heart disease.
    Eur Heart J. 2023;44:445-447.
    >> Share

    Prognostic interpretation of serial high-sensitivity cardiac troponin in patients presenting with suspected acute coronary syndrome.
    Eur Heart J. 2023;44:513-515.
    >> Share

  45. PAREEK M, Kragholm KH, Kristensen AMD, Vaduganathan M, et al
    Serial troponin-T and long-term outcomes in suspected acute coronary syndrome.
    Eur Heart J. 2023;44:502-512.
    >> Share

  46. YAMAMOTO H, Fujii M, Takaya T
    High-risk calcified plaque preoperatively detected by non-contrast T1-weighted magnetic resonance imaging and electrocardiogram-gated computed tomography.
    Eur Heart J. 2023;44:534.
    >> Share

  47. OZKAN J
    Small country big difference: how one physician's vision became a reality and transformed acute myocardial infarction management in the Republic of Mauritius.
    Eur Heart J. 2023 Feb 3:ehad012. doi: 10.1093.
    >> Share

  48. THYGESEN K, Jaffe AS
    Potential risks of non-cardiac peri-operative myocardial infarction/injury.
    Eur Heart J. 2023 Feb 1:ehac768. doi: 10.1093.
    >> Share

  49. GERSH BJ, De Mets D
    Revascularization in ischaemic cardiomyopathy: how to interpret current evidence.
    Eur Heart J. 2023;44:365-367.
    >> Share

  50. VERGALLO R, Volpe M
    A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGE.
    Eur Heart J. 2023;44:340-341.
    >> Share

    January 2023
  51. PUELACHER C, Gualandro DM, Glarner N, Lurati Buse G, et al
    Long-term outcomes of perioperative myocardial infarction/injury after non-cardiac surgery.
    Eur Heart J. 2023 Jan 27:ehac798. doi: 10.1093.
    >> Share

  52. CREA F
    Ischaemic heart disease: antithrombotic treatment and new therapeutic targets.
    Eur Heart J. 2023;44:239-242.
    >> Share

  53. KATO ET, Morrow DA, Guo J, Berg DD, et al
    Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
    Eur Heart J. 2023;44:293-300.
    >> Share

  54. GALLI M, Ortega-Paz L, Angiolillo DJ
    Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot.
    Eur Heart J. 2023;44:236.
    >> Share

  55. XIE C, Zhang Y, Lin J
    Are there other factors that influence the assessment of bleeding risk comparing potent P2Y12 inhibitors with clopidogrel?
    Eur Heart J. 2023;44:235.
    >> Share

  56. CREA F
    Hot topics in ischaemic heart disease: polygenic risk scores, coronary microvascular dysfunction, myocardial injury, and diagnostic role of imaging.
    Eur Heart J. 2023;44:73-76.
    >> Share

  57. NEGLIA D, Liga R, Gimelli A, Podlesnikar T, et al
    Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry.
    Eur Heart J. 2023;44:142-158.
    >> Share

  58. PEPINE CJ, Bairey Merz CN
    Heart and brain interactions: is small vessel disease a link?
    Eur Heart J. 2023;44:126-128.
    >> Share

  59. MEJIA-RENTERIA H, Travieso A, Matias-Guiu JA, Yus M, et al
    Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study).
    Eur Heart J. 2023;44:113-125.
    >> Share

  60. RAY KK, Raal FJ, Kallend DG, Jaros MJ, et al
    Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
    Eur Heart J. 2023;44:129-138.
    >> Share

  61. OMRAN H
    Troponin for risk stratification after CABG: just one piece of the puzzle.
    Eur Heart J. 2023;44:163-164.
    >> Share

  62. CHEN T, Zhou H, Guo J, Chen Y, et al
    Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast rotational atherectomy for calcified coronary lesions.
    Eur Heart J. 2023;44:166.
    >> Share

    December 2022
  63. TARDIF JC, Pfeffer MA, Dube MP
    Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome.
    Eur Heart J. 2022;43:5062-5063.
    >> Share

    dal-GenE was negative-not positive except for COVID-19.
    Eur Heart J. 2022;43:5061.
    >> Share

  65. FUKAMACHI D, Okumura Y
    Growing giant coronary artery aneurysm.
    Eur Heart J. 2022;43:5065.
    >> Share

  66. HUBER K
    Platelet antiaggregation after an acute coronary syndrome: what about the elderly?
    Eur Heart J. 2022;43:5045-5046.
    >> Share

  67. GIBLETT JP, Matetic A, Jenkins D, Ng CY, et al
    Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry.
    Eur Heart J. 2022;43:5020-5032.
    >> Share

  68. ALFONSO F, Aguilar R, Reyes G
    Management of post-infarction ventricular septal defects: are we moving forward?
    Eur Heart J. 2022;43:5033-5036.
    >> Share

  69. LEE JM, Kim HK, Park KH, Choo EH, et al
    Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
    Eur Heart J. 2022 Dec 20:ehac763. doi: 10.1093.
    >> Share

    Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long term.
    Eur Heart J. 2022 Dec 20:ehac714. doi: 10.1093.
    >> Share

  71. DAVIDSON JA, Banerjee A, Douglas I, Leyrat C, et al
    Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.
    Eur Heart J. 2022 Dec 20:ehac737. doi: 10.1093.
    >> Share

  72. COUGHLAN JJ, Ibanez B
    Reperfusion in ST-elevation myocardial infarction: delays have dangerous ends.
    Eur Heart J. 2022 Dec 14:ehac723. doi: 10.1093.
    >> Share

  73. HOLMSTROM L, Juntunen S, Vahatalo J, Pakanen L, et al
    Plaque histology and myocardial disease in sudden coronary death: the Fingesture study.
    Eur Heart J. 2022;43:4923-4930.
    >> Share

  74. NISHIHIRA K, Shibata Y, Asada Y
    Intraplaque haemorrhage in rapidly progressing coronary atheroma: insights from histopathological analysis of atherectomy specimens.
    Eur Heart J. 2022;43:4964.
    >> Share

  75. VERGALLO R, Patrono C
    A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction.
    Eur Heart J. 2022 Dec 7:ehac732. doi: 10.1093.
    >> Share

  76. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    >> Share

  77. EL-CHOULI M, Meddis A, Christensen DM, Gerds TA, et al
    Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study.
    Eur Heart J. 2022 Dec 7:ehac727. doi: 10.1093.
    >> Share

  78. COSTA F, Montalto C, Branca M, Hong SJ, et al
    Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
    Eur Heart J. 2022 Dec 7:ehac706. doi: 10.1093.
    >> Share

  79. LIBERALE L, Puspitasari YM, Ministrini S, Akhmedov A, et al
    JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study.
    Eur Heart J. 2022 Dec 5:ehac641. doi: 10.1093.
    >> Share

  80. JAMAL J, Idris H, Faour A, Yang W, et al
    Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.
    Eur Heart J. 2022 Dec 2:ehac661. doi: 10.1093.
    >> Share

  81. HAN Y
    Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease.
    Eur Heart J. 2022 Dec 2:ehac625. doi: 10.1093.
    >> Share

  82. PEDICINO D, Liuzzo G
    Mind the map: a multi-omic approach to post-ischaemic cardiac remodelling paves the way for future cardiovascular research.
    Eur Heart J. 2022;43:4677-4678.
    >> Share

  83. LECOEUR E, Domenge O, Fayol A, Jannot AS, et al
    Epidemiology of heart failure in young adults: a French nationwide cohort study.
    Eur Heart J. 2022 Dec 1:ehac651. doi: 10.1093.
    >> Share

    November 2022
  84. CHRISTENSEN DM, Schjerning AM, Smedegaard L, Charlot MG, et al
    Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study.
    Eur Heart J. 2022 Nov 26:ehac667. doi: 10.1093.
    >> Share

  85. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    >> Share

  86. CREA F
    Controversies in cardiac surgery: left main coronary disease, arterial myocardial revascularization, and prosthetic valves in dialysis.
    Eur Heart J. 2022;43:4603-4605.
    >> Share

  87. KITE TA, Bountziouka V, Ladwiniec A
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: risk and reward?
    Eur Heart J. 2022;43:4661.
    >> Share

  88. ALADIN AI, Zhang C, Waksman R
    Timing of early invasive strategy in patients with non-ST-elevation acute coronary syndrome.
    Eur Heart J. 2022;43:4660.
    >> Share

  89. GONG X, Shen J, Liu L, Xiao Z, et al
    Pulmonary trunk compression due to multiple aneurysms associated with a coronary-pulmonary artery fistula.
    Eur Heart J. 2022;43:4662.
    >> Share

  90. TAGGART DP, Audisio K, Gerry S, Robinson NB, et al
    Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial.
    Eur Heart J. 2022;43:4644-4652.
    >> Share

  91. HOLMSTROM L, Chugh SS
    How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
    Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
    >> Share

  92. VAN DEN BROEK WWA, Ten Berg JM
    Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
    Eur Heart J. 2022;43:4599-4600.
    >> Share

  93. BONACA MP, Im K, Magnani G, Bansilal S, et al
    Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2022 Nov 11. pii: 6823782. doi: 10.1093.
    >> Share

  94. PATHAK S, Lai FY, Miksza J, Petrie MC, et al
    Surgical or Percutaneous Coronary Revascularisation for Heart Failure: An In Silico Model using Routinely Collected Health Data to Emulate a Clinical Trial.
    Eur Heart J. 2022 Nov 9. pii: 6815617. doi: 10.1093.
    >> Share

  95. HEUTS S, Gollmann-Tepekoylu C, Denessen EJS, Olsthoorn JR, et al
    Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications.
    Eur Heart J. 2022 Nov 7. pii: 6807330. doi: 10.1093.
    >> Share

  96. FONSECA HAR, Furtado RHM, Zimerman A, Lemos PA, et al
    Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
    Eur Heart J. 2022;43:4378-4388.
    >> Share

    Influenza vaccine in cardiovascular disease: time to move the needle.
    Eur Heart J. 2022;43:4389-4391.
    >> Share

    October 2022
  98. GARCIA R, Marijon E, Karam N, Narayanan K, et al
    Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
    Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
    >> Share

  99. HEYNE S, Macherey S, Meertens MM, Braumann S, et al
    Coronary angiography after cardiac arrest without ST-elevation myocardial infarction: a network meta-analysis.
    Eur Heart J. 2022 Oct 27. pii: 6775293. doi: 10.1093.
    >> Share

  100. VERGALLO R, Volpe M
    Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR.
    Eur Heart J. 2022 Oct 26. pii: 6774407. doi: 10.1093.
    >> Share

  101. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    >> Share

  102. TYBJAERG-HANSEN A, Nordestgaard LT, Christoffersen M
    Pharmacogenetics-guided CETP inhibition: an open question?
    Eur Heart J. 2022;43:3957-3959.
    >> Share

  103. TARDIF JC, Pfeffer MA, Kouz S, Koenig W, et al
    Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
    Eur Heart J. 2022;43:3947-3956.
    >> Share

  104. VERGALLO R, Liuzzo G
    The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
    Eur Heart J. 2022 Oct 10. pii: 6754626. doi: 10.1093.
    >> Share

  105. VERGALLO R, Liuzzo G
    Coronary artery calcium scoring for cardiovascular risk stratification: more pitfalls than advantages?
    Eur Heart J. 2022;43:3510-3511.
    >> Share

  106. GOTO S, Goto S
    Potent antithrombotic treatments in Asian vs. non-Asian patients.
    Eur Heart J. 2022;43:3553-3555.
    >> Share

  107. HORI M, Zhu J, Liang Y, Bhatt DL, et al
    Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial.
    Eur Heart J. 2022;43:3542-3552.
    >> Share

    September 2022
  108. ARMSTRONG PW, Bates ER, Gaudino M
    Left main coronary disease: evolving management concepts.
    Eur Heart J. 2022 Sep 29. pii: 6731216. doi: 10.1093.
    >> Share

  109. HESS CN, Bonaca MP
    Risk of remnants and remnant risk in peripheral artery disease.
    Eur Heart J. 2022;43:3270-3272.
    >> Share

  110. MARQUINA C, Lacaze P, Tiller J, Riaz M, et al
    Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
    Eur Heart J. 2022;43:3243-3254.
    >> Share

  111. VERGALLO R, Pedicino D
    Which mechanical circulatory support device in acute myocardial infarction complicated by cardiogenic shock?
    Eur Heart J. 2022 Sep 6. pii: 6692466. doi: 10.1093.
    >> Share

  112. CREA F
    Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease.
    Eur Heart J. 2022;43:3087-3091.
    >> Share

  113. NADARAJAH R, Wu J, Hurdus B, Asma S, et al
    The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.
    Eur Heart J. 2022;43:3164-3178.
    >> Share

  114. SPIRITO A, Cao D, Mehran R
    Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.
    Eur Heart J. 2022;43:3145-3147.
    >> Share

  115. LANCELLOTTI P, Go YY, Nchimi A
    Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg?
    Eur Heart J. 2022;43:3129-3131.
    >> Share

  116. DRIESSEN RS, van Diemen PA, Raijmakers PG, Knuuti J, et al
    Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.
    Eur Heart J. 2022;43:3118-3128.
    >> Share

  117. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2022;43:3148-3161.
    >> Share

  118. GUEDENEY P, Thiele H, Collet JP
    Timing of invasive management of NSTE-ACS: is the time up for early management?
    Eur Heart J. 2022;43:3161-3163.
    >> Share

    August 2022
  119. VON LEWINSKI D, Kolesnik E, Tripolt NJ, Pferschy PN, et al
    Empagliflozin in acute Myocardial Infarction: the EMMY trial.
    Eur Heart J. 2022 Aug 29. pii: 6677315. doi: 10.1093.
    >> Share

  120. HARRINGTON J, Anker S, Butler J
    Putting the Puzzle Together: SGLT2 Inhibitors from Prevention to Treatment of Heart Failure.
    Eur Heart J. 2022 Aug 29. pii: 6677316. doi: 10.1093.
    >> Share

  121. GIDDING SS, Colangelo LA, Nwabuo CC, Lewis CE, et al
    PDAY risk score predicts cardiovascular events in young adults: the CARDIA study.
    Eur Heart J. 2022;43:2892-2900.
    >> Share

    July 2022
  122. DOLEJSI T, Delgobo M, Schuetz T, Tortola L, et al
    Adult T-cells impair neonatal cardiac regeneration.
    Eur Heart J. 2022;43:2698-2709.
    >> Share

  123. Corrigendum to: Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
    Eur Heart J. 2022 Jul 6. pii: 6632321. doi: 10.1093.
    >> Share

  124. GAUDINO M, Farkouh ME, Stone GW
    Left main revascularization: an evidence-based reconciliation.
    Eur Heart J. 2022;43:2421-2424.
    >> Share

  125. FISCHER J, Godecke A, Kelm M, Heusch G, et al
    Master switches in cardiac ischaemia: the Collaborative Research Center (CRC) 1116 of the German Research Foundation.
    Eur Heart J. 2022;43:2350-2351.
    >> Share

    June 2022
  126. CREA F
    Antiplatelet treatment of acute coronary syndromes: novel clinical and translational perspectives.
    Eur Heart J. 2022;43:2253-2256.
    >> Share

  127. ZHU H, Chen T, Huang J
    An attempt to better show some results such as the comparison of mortality and major adverse cardiovascular events between the abnormal and normal coronary flow reserve cohorts.
    Eur Heart J. 2022;43:2338-2339.
    >> Share

  128. SCHIELE F, Meneveau N
    NSTEMI management: a fall from GRACE?
    Eur Heart J. 2022;43:2300-2302.
    >> Share

  129. TAKEI Y, Abe N, Bohgaki M, Kasahara H, et al
    Paradoxical enlargement of immunoglobulin G4 (IgG4)-related coronary aneurysms despite controlling serum IgG4 level.
    Eur Heart J. 2022;43:2250.
    >> Share

  130. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    >> Share

    May 2022
  131. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
    Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
    >> Share

  132. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    >> Share

  133. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    >> Share

    Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk.
    Eur Heart J. 2022;43:1861-1863.
    >> Share

  135. KRALER S, Wenzl FA, Georgiopoulos G, Obeid S, et al
    Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
    Eur Heart J. 2022;43:1849-1860.
    >> Share

  136. WANG J, Chen H, Zhang L
    Coronary artery fistula bypassed the left main coronary artery blocked by a large cardiogenic thrombus.
    Eur Heart J. 2022;43:1885.
    >> Share

  137. LU X, Liu Z, Cui Q, Liu F, et al
    A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
    Eur Heart J. 2022;43:1702-1711.
    >> Share

  138. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
    Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Eur Heart J. 2022;43:1715-1727.
    >> Share

  139. FRANTZ S, Hundertmark MJ, Schulz-Menger J, Bengel FM, et al
    Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
    Eur Heart J. 2022 May 4. pii: 6578707. doi: 10.1093.
    >> Share

    April 2022
  140. CREA F
    Inflammation, targeted proteomics, and microvascular dysfunction: the new frontiers of ischaemic heart disease.
    Eur Heart J. 2022;43:1517-1520.
    >> Share

  141. STEFFENS S, Nahrendorf M, Madonna R
    Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies.
    Eur Heart J. 2022;43:1533-1541.
    >> Share

  142. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
    Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1582-1593.
    >> Share

  143. MORICI N, De Servi S, De Luca L, Crimi G, et al
    Management of acute coronary syndromes in older adults.
    Eur Heart J. 2022;43:1542-1553.
    >> Share

  144. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
    Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1582-1593.
    >> Share

  145. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    >> Share

  146. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    >> Share

  147. SAMMONS E, Hopewell JC, Chen F, Stevens W, et al
    Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
    Eur Heart J. 2022;43:1416-1424.
    >> Share

  148. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
    Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
    Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
    >> Share

    March 2022
  149. BUCCIARELLI-DUCCI C, Ajmone-Marsan N, Di Carli M, Nicol E, et al
    The year in cardiovascular medicine 2021: imaging.
    Eur Heart J. 2022;43:1288-1295.
    >> Share

  150. BYRNE RA, Rai H, Colleran R
    Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?
    Eur Heart J. 2022;43:1331-1333.
    >> Share

  151. HAN Y
    Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease.
    Eur Heart J. 2022;43:1283-1285.
    >> Share

  152. ROMAGUERA R, Salinas P, Gomez-Lara J, Brugaletta S, et al
    Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
    Eur Heart J. 2022;43:1320-1330.
    >> Share

  153. OKA S, Endo H, Takagi K, Yamagata K, et al
    Mechanical coronary artery stenosis induced by active fixation left ventricular lead: a case of acute complication after cardiac resynchronization therapy device implantation.
    Eur Heart J. 2022;43:1271.
    >> Share

  154. THYGESEN K, Jaffe AS
    Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
    Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
    >> Share

  155. HAN Y, Li Y
    Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
    Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
    >> Share

  156. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
    P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
    >> Share

  157. TUAL-CHALOT S, Stellos K
    Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarction.
    Eur Heart J. 2022 Mar 10. pii: 6546087. doi: 10.1093.
    >> Share

  158. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
    Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
    Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
    >> Share

  159. TAN S, White HD, Layland J
    Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based?
    Eur Heart J. 2022;43:1008-1011.
    >> Share

  160. SILVAIN J, Hausenloy D, Zeitouni M
    Appropriate criteria for the definition of Type 4a MI.
    Eur Heart J. 2022;43:1013-1014.
    >> Share

    February 2022
  161. MOLEDINA SM, Kontopantelis E, Wijeysundera HC, Banerjee S, et al
    Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study.
    Eur Heart J. 2022 Feb 24. pii: 6529720. doi: 10.1093.
    >> Share

  162. ZENG C, Rosenberg L, Li X, Djousse L, et al
    Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
    Eur Heart J. 2022 Feb 24. pii: 6535634. doi: 10.1093.
    >> Share

  163. PRICE S, Katz J, Kaufmann CC, Huber K, et al
    The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease.
    Eur Heart J. 2022;43:800-806.
    >> Share

  164. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
    Frailty and cardiovascular mortality in more than 3 million US Veterans.
    Eur Heart J. 2022;43:818-826.
    >> Share

  165. VAROTTO L, De Boni A, Iannucci G, Caprioglio F, et al
    Uncommon intravascular lithotripsy for the treatment of subclavian steal syndrome: a case presenting with concomitant acute coronary syndrome and transient ischaemic attack.
    Eur Heart J. 2022;43:840.
    >> Share

  166. LIUZZO G, Volpe M
    Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
    Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
    >> Share

  167. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
    High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
    Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
    >> Share

  168. LIUZZO G, Volpe M
    PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction.
    Eur Heart J. 2022;43:559-560.
    >> Share

  169. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
    Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
    Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
    >> Share

  170. DE CATERINA R, Liga R, Boden WE
    Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
    Eur Heart J. 2022;43:387-390.
    >> Share

    January 2022
    How to live to 100 before developing clinical coronary artery disease: a suggestion.
    Eur Heart J. 2022;43:249-250.
    >> Share

  172. SLIWICKA O, Damman P, Habets J
    Stress dynamic CT perfusion in the evaluation of acute coronary syndrome.
    Eur Heart J. 2022;43:244.
    >> Share

  173. CREA F
    Hot topics in ischaemic heart disease: revascularization, hibernation, type 2 infarction, and proteomics.
    Eur Heart J. 2022;43:89-92.
    >> Share

  174. NEWBY LK
    A new biomarker of acute coronary ischaemia: from bench to bedside?
    Eur Heart J. 2022;43:164-166.
    >> Share

  175. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
    Myocardial viability testing: all STICHed up, or about to be REVIVED?
    Eur Heart J. 2022;43:118-126.
    >> Share

  176. CUBEDO J, Padro T, Vilahur G, Crea F, et al
    Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events.
    Eur Heart J. 2022;43:153-163.
    >> Share

  177. QUADRI G, Tomassini F, Cerrato E, Varbella F, et al
    Emergency treatment of a giant coronary aneurysm: percutaneous intervention with coronary and peripheral tools.
    Eur Heart J. 2022;43:168.
    >> Share

  178. DEMIR OM, Rahman H, van de Hoef TP, Escaned J, et al
    Invasive and non-invasive assessment of ischaemia in chronic coronary syndromes: translating pathophysiology to clinical practice.
    Eur Heart J. 2022;43:105-117.
    >> Share

    December 2021
  179. WANG R, Serruys PW, Gao C, Hara H, et al
    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
    Eur Heart J. 2021;43:56-67.
    >> Share

  180. NICOLAS J, Giustino G, Dangas G
    Periprocedural myocardial infarction: multiple definitions and still a quest for consensus.
    Eur Heart J. 2021 Dec 21. pii: 6471447. doi: 10.1093.
    >> Share

  181. LOZANO I, Vegas JM, Rondan J
    Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
    Eur Heart J. 2021;42:4981.
    >> Share

  182. WHITE HD, Schwartz GG, Szarek M, Bhatt DL, et al
    Alirocumab after acute coronary syndrome in patients with a history of heart failure.
    Eur Heart J. 2021 Dec 18. pii: 6469637. doi: 10.1093.
    >> Share

  183. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    >> Share

  184. CREA F
    Percutaneous coronary interventions: more complex than fixing stenoses.
    Eur Heart J. 2021;42:4607-4611.
    >> Share

  185. WHITE HD
    Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
    Eur Heart J. 2021;42:4697-4698.
    >> Share

  186. AL-LAMEE R, Mintz GS
    What are the PROSPECTs and clinical implications of vulnerable plaque?
    Eur Heart J. 2021;42:4680-4682.
    >> Share

  187. KEDHI E, Berta B, Roleder T, Hermanides RS, et al
    Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.
    Eur Heart J. 2021;42:4671-4679.
    >> Share

  188. AL-LAMEE R, Mintz GS
    What are the PROSPECTs and clinical implications of vulnerable plaque?
    Eur Heart J. 2021;42:4680-4682.
    >> Share

    November 2021
  189. EGGERS KM, James SK, Lindahl B
    Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
    Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
    >> Share

  190. BOR WL, Ten Berg JM
    Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
    Eur Heart J. 2021;42:4562-4564.
    >> Share

  191. DE SILVA R, Cheng K
    Microvascular angina: quo tendimus?
    Eur Heart J. 2021;42:4601-4604.
    >> Share

  192. SHIMOKAWA H, Suda A, Takahashi J, Berry C, et al
    Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.
    Eur Heart J. 2021;42:4592-4600.
    >> Share

  193. PITT B, Ferreira JP, Zannad F
    Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
    Eur Heart J. 2021 Nov 12. pii: 6425576. doi: 10.1093.
    >> Share

  194. CHIKWE J, Alfieri OR
    The optimal strategy for multivessel coronary revascularization.
    Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
    >> Share

  195. WINTHER S, Schmidt SE, Knuuti J, Bottcher M, et al
    Selecting the right cohorts and endpoints for the validation of pre-test probability models for obstructive coronary artery disease.
    Eur Heart J. 2021;42:4402-4403.
    >> Share

  196. DERIMAY F, Finet G, Rioufol G
    Coronary artery stenosis prediction does not mean coronary artery stenosis obstruction.
    Eur Heart J. 2021;42:4401.
    >> Share

  197. EGIDY ASSENZA G, Dimopoulos K, Budts W, Donti A, et al
    Management of acute cardiovascular complications in pregnancy.
    Eur Heart J. 2021;42:4224-4240.
    >> Share

    October 2021
  198. BIAN L, Fang Z, Qian H, Wu Z, et al
    Dumbbell on the heart: two giant left coronary artery aneurysms in an adolescent.
    Eur Heart J. 2021;42:4195.
    >> Share

  199. AHN JM, Zimmermann FM, Arora S, Solberg OG, et al
    Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
    Eur Heart J. 2021 Oct 19. pii: 6401958. doi: 10.1093.
    >> Share

  200. TSUDA K, Kanzaki Y, Hoshiga M
    Early cardiac magnetic resonance leads to diagnose the etiology of myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2021 Oct 18. pii: 6400298. doi: 10.1093.
    >> Share

  201. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
    Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
    Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
    >> Share

  202. GALLI M, Angiolillo DJ
    Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope?
    Eur Heart J. 2021;42:4037-4039.
    >> Share

  203. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.
    Eur Heart J. 2021 Oct 11. pii: 6386704. doi: 10.1093.
    >> Share

  204. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    >> Share

  205. CREA F
    The challenge of risk stratification in suspected angina, in myocardial infarction without risk factors, and in frail patients.
    Eur Heart J. 2021;42:3807-3811.
    >> Share

  206. CURZEN N, Nicholas Z, Stuart B, Wilding S, et al
    Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.
    Eur Heart J. 2021;42:3844-3852.
    >> Share

  207. JAFFER FA, Mehilli J, Escaned J
    Left main coronary disease at the bifurcation: should the pendulum swing back towards the provisional stenting approach?
    Eur Heart J. 2021;42:3840-3843.
    >> Share

  208. SENIOR R, Khattar R
    Stress echocardiography: the quest for risk stratification beyond myocardial ischaemia.
    Eur Heart J. 2021;42:3879-3881.
    >> Share

  209. AVIS SR, Vernon ST, Hagstrom E, Figtree GA, et al
    Coronary artery disease in the absence of traditional risk factors: a call for action.
    Eur Heart J. 2021;42:3822-3824.
    >> Share

  210. MENG SW, Ko TY, Hsieh MY
    Simultaneous acute pulmonary and coronary embolism.
    Eur Heart J. 2021;42:3888.
    >> Share

    September 2021
  211. HAN Y
    Long-term outcomes of new-generation coronary stents in China.
    Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
    >> Share

  212. SINHA A, Rahman H, Webb A, Shah AM, et al
    Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Eur Heart J. 2021 Sep 16. pii: 6371296. doi: 10.1093.
    >> Share

  213. PETERS SAE, Kluin J
    Why do women do worse after coronary artery bypass grafting?
    Eur Heart J. 2021 Sep 15. pii: 6370651. doi: 10.1093.
    >> Share

  214. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    >> Share

  215. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    >> Share

  216. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    >> Share

  217. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    >> Share

    August 2021
  218. CREA F
    Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment.
    Eur Heart J. 2021;42:3109-3113.
    >> Share

  219. YANG Q, Sun D, Pei C, Zeng Y, et al
    LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
    Eur Heart J. 2021;42:3175-3186.
    >> Share

  220. CERRATO E, Giacobbe F, Quadri G, Macaya F, et al
    Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
    Eur Heart J. 2021;42:3161-3171.
    >> Share

  221. LUSEBRINK E, Massberg S, Orban M
    The lack of evidence-based therapeutic strategies for left ventricular unloading during venoarterial extracorporeal membrane oxygenation therapy calls for randomized trials.
    Eur Heart J. 2021;42:3105-3106.
    >> Share

  222. KLOECKNER M, Guihaire J, Hascoet S
    Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
    Eur Heart J. 2021;42:3103-3104.
    >> Share

  223. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    >> Share

  224. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    >> Share

    July 2021
  225. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    >> Share

  226. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    >> Share

  227. COLLISON D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, et al
    Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial.
    Eur Heart J. 2021 Jul 19. pii: 6323924. doi: 10.1093.
    >> Share

    May 2021
  228. NAVARESE EP, Lansky AJ, Kereiakes DJ, Kubica J, et al
    Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
    Eur Heart J. 2021 May 18. pii: 6276780. doi: 10.1093.
    >> Share

  229. HILDICK-SMITH D, Egred M, Banning A, Brunel P, et al
    The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
    Eur Heart J. 2021 May 18. pii: 6276782. doi: 10.1093.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016